As a part of its life cycle, human immunodeficiency virus-1 (HIV-1) inserts a copy of its DNA into human immune cells. Some of these newly infected immune cells can then transition into a dormant, ...
The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...
The results of three randomized, controlled trials (SAPiT, STRIDE, and CAMELIA) demonstrate that, for coinfected patients with advanced immunosuppression, the survival benefit of starting ART within ...
Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...
Research into this new way of treating HIV is only beginning. When it was first named in 1983, HIV was thought to be a death sentence. The virus replicated rapidly in the people it infected because ...
Advancements in HIV/AIDS research, drug development, and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check ...
The patient, who had a history of undetectable HIV-1 RNA levels since 1997 while receiving antiretroviral therapy, had remission from AML after salvage chemotherapy (Table S2). HCT was recommended for ...
Scanning electron micrograph showing HIV (yellow) attacking a human T cell (blue). In a new study, Johns Hopkins Medicine-led researchers report on a person living with HIV who had a dramatic drop in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results